Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line <em>Helicobacter pylori</em> Eradication: An Intervention Study in Southern Italy
The eradication of <i>Helicobacter pylori</i> (<i>H. pylori</i>) may be difficult due to antibiotic resistance. Indeed, after one failure, a second-line therapy is needed and a bismuth containing quadruple therapy (BQT) with a three-in-one capsule formulation is becoming very...
Autors principals: | , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
MDPI AG
2022-01-01
|
Col·lecció: | Antibiotics |
Matèries: | |
Accés en línia: | https://www.mdpi.com/2079-6382/11/1/78 |